These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 36291885)

  • 1. Downstaging Therapies for Patients with Hepatocellular Carcinoma Awaiting Liver Transplantation: A Systematic Review and Meta-Analysis on Intention-to-Treat Outcomes.
    Di Martino M; Vitale A; Ferraro D; Maniscalco M; Pisaniello D; Arenga G; Falaschi F; Terrone A; Iacomino A; Galeota Lanza A; Esposito C; Cillo U; Vennarecci G
    Cancers (Basel); 2022 Oct; 14(20):. PubMed ID: 36291885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bridging therapies for patients with hepatocellular carcinoma awaiting liver transplantation: A systematic review and meta-analysis on intention-to-treat outcomes.
    Di Martino M; Ferraro D; Pisaniello D; Arenga G; Falaschi F; Terrone A; Maniscalco M; Galeota Lanza A; Esposito C; Vennarecci G
    J Hepatobiliary Pancreat Sci; 2023 Apr; 30(4):429-438. PubMed ID: 36207763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. International study on the outcome of locoregional therapy for liver transplant in hepatocellular carcinoma beyond Milan criteria.
    Degroote H; Piñero F; Costentin C; Notarpaolo A; Boin IF; Boudjema K; Baccaro C; Chagas AL; Bachellier P; Ettorre GM; Poniachik J; Muscari F; Di Benedetto F; Duque SH; Salame E; Cillo U; Gadano A; Vanlemmens C; Fagiuoli S; Rubinstein F; Burra P; Cherqui D; Silva M; Van Vlierberghe H; Duvoux C;
    JHEP Rep; 2021 Oct; 3(5):100331. PubMed ID: 34485882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcomes of hepatocellular carcinoma that underwent chemoembolization for bridging or downstaging.
    Affonso BB; Galastri FL; da Motta Leal Filho JM; Nasser F; Falsarella PM; Cavalcante RN; de Almeida MD; Felga GEG; Valle LGM; Wolosker N
    World J Gastroenterol; 2019 Oct; 25(37):5687-5701. PubMed ID: 31602168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival benefit of transplantation for recurrence of hepatocellular carcinoma after liver resection.
    Tuci F; Vitale A; D'Amico F; Gringeri E; Neri D; Zanus G; Bassi D; Polacco M; Boetto R; Lodo E; Germani G; Burra P; Angeli P; Cillo U
    Transplant Proc; 2014 Sep; 46(7):2287-9. PubMed ID: 25242770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bridging and downstaging treatments for hepatocellular carcinoma in patients on the waiting list for liver transplantation.
    Pompili M; Francica G; Ponziani FR; Iezzi R; Avolio AW
    World J Gastroenterol; 2013 Nov; 19(43):7515-30. PubMed ID: 24282343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapies for patients with hepatocellular carcinoma awaiting liver transplantation: A systematic review and meta-analysis.
    Kulik L; Heimbach JK; Zaiem F; Almasri J; Prokop LJ; Wang Z; Murad MH; Mohammed K
    Hepatology; 2018 Jan; 67(1):381-400. PubMed ID: 28859222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver Transplantation for Advanced Hepatocellular Carcinoma after Downstaging Without Up-Front Stage Restrictions.
    Chapman WC; Garcia-Aroz S; Vachharajani N; Fowler K; Saad N; Lin Y; Wellen J; Tan B; Khan AS; Doyle MB
    J Am Coll Surg; 2017 Apr; 224(4):610-621. PubMed ID: 28069527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morphological features of advanced hepatocellular carcinoma as a predictor of downstaging and liver transplantation: an intention-to-treat analysis.
    Barakat O; Wood RP; Ozaki CF; Ankoma-Sey V; Galati J; Skolkin M; Toombs B; Round M; Moore W; Mieles L
    Liver Transpl; 2010 Mar; 16(3):289-99. PubMed ID: 20209588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocellular Carcinoma and Liver Transplantation: Changing Patterns and Practices.
    Rich NE; Parikh ND; Singal AG
    Curr Treat Options Gastroenterol; 2017 Jun; 15(2):296-304. PubMed ID: 28425018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of loco-regional treatment for hepatocellular carcinoma prior to living donor liver transplantation: a report from a single center in Egypt.
    Shaker MK; Montasser IF; Sakr M; Elgharib M; Dabbous HM; Ebada H; Dorry AE; Bahaa M; Meteini ME
    J Hepatocell Carcinoma; 2018; 5():29-36. PubMed ID: 29520343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microwave ablation after downstaging of hepatocellular carcinoma: outcome was similar to tumor within Milan criteria.
    Shi F; Lian S; Mai Q; Mo Z; Zhuang W; Cui W; Shen L; Chen M; Wu P; Chen X
    Eur Radiol; 2020 May; 30(5):2454-2462. PubMed ID: 32002636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Live donor liver transplantation for patients with hepatocellular carcinoma offers increased survival vs. deceased donation.
    Goldaracena N; Gorgen A; Doyle A; Hansen BE; Tomiyama K; Zhang W; Ghanekar A; Lilly L; Cattral M; Galvin Z; Selzner M; Bhat M; Selzner N; McGilvray I; Greig PD; Grant DR; Sapisochin G
    J Hepatol; 2019 Apr; 70(4):666-673. PubMed ID: 30630009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of loco-regional therapy for down-staging of hepatocellular carcinoma prior to liver transplantation.
    Shi XJ; Jin X; Wang MQ; Wei LX; Ye HY; Liang YR; Luo Y; Dong JH
    Hepatobiliary Pancreat Dis Int; 2011 Apr; 10(2):143-50. PubMed ID: 21459720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Section 3. Current status of downstaging of hepatocellular carcinoma before liver transplantation.
    Sharr WW; Chan SC; Lo CM
    Transplantation; 2014 Apr; 97 Suppl 8():S10-7. PubMed ID: 24849822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downstaging hepatocellular carcinoma: A systematic review and pooled analysis.
    Parikh ND; Waljee AK; Singal AG
    Liver Transpl; 2015 Sep; 21(9):1142-52. PubMed ID: 25981135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Pretransplant Treatments for Patients with Hepatocellular Carcinoma Waiting for Liver Transplantation.
    Ogawa K; Takada Y
    Cancers (Basel); 2022 Jan; 14(2):. PubMed ID: 35053558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downstaging of hepatocellular cancer before liver transplant: long-term outcome compared to tumors within Milan criteria.
    Yao FY; Mehta N; Flemming J; Dodge J; Hameed B; Fix O; Hirose R; Fidelman N; Kerlan RK; Roberts JP
    Hepatology; 2015 Jun; 61(6):1968-77. PubMed ID: 25689978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocellular carcinoma downstaging in liver transplantation.
    Yu CY; Ou HY; Huang TL; Chen TY; Tsang LL; Chen CL; Cheng YF
    Transplant Proc; 2012 Mar; 44(2):412-4. PubMed ID: 22410030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.